In This Section

Update on the Gaseous Signaling Molecules NO, H2S, and CO

Sunday April 22, 2018

3:30 pm - 6:00 pm Eastern Time (ET)

Room 17A


Chair :

Andreas Papapetropoulos
National and Kapodistrian University of Athens

Nathan Bryan
HumanN, Inc.

Gasotransmitters (NO, CO and H2S) have been implicated in a plethora of physiological and pathophysiological processes including angiogenesis, atherosclerosis, blood pressure regulation and cardioprotection, attracting wide attention among basic scientists and clinicians. During this symposium, recent progress in the biology and cardiovascular pharmacology of gasotransmitters, as well as the importance of their cross-talk will be highlighted. The topics presented span the entire spectrum from basic science to clinical trials of gasotransmitter-related molecules. The symposium targets a wide audience that includes pharmacologists, physiologists, biochemists and nutritionists.


Andreas Papapetropoulos - National and Kapodistrian University of Athens

Introduction to Gasotransmitters: An Update

Ingrid Fleming - Goethe University

Life after the Nobel Prize: Novel Mechanisms of eNOS Regulation Impacting Cardiovascular Function

David Lefer - Louisiana State University

Hydrogen Sulfide Therapy in Heart Failure

Nanduri Prabhakar - University of Chicago

Regulation of Carotid Body Activity by the Heme Oxygensase/CO Pathway

Nathan Bryan - HumanN, Inc.

Natural Product Chemistry and Nitric Oxide Production: New Strategies for NO Based Therapeutics

Amrita Ahluwalia - Queen Mary University of London

Dietary Nitrate Improves Cardiovascular Health in Humans

Zhen Li - LSU Health Sciences Center - NO

Delayed Therapy with A Hydrogen Sulfide Donor, JK1, Protects against Pressure Overload - Induced Heart Failure